Access Now

Look up NPI Number
CE InformationCourse Progress
  • Access Webcast
  • Download PDF of Slides
  • Evaluation
  • Certificate
Evaluation

Preventing Bloodstream Infections in the Vascular Access Patient: Addressing Intraluminal and Extraluminal VAD Contamination

Evaluation

HMP Education would appreciate your feedback on the quality and impact of this activity.

Please answer the following questions, some of which include a 5-point Likert scale (5 = strongly agree/excellent/great deal; 1 = strongly disagree/poor/very little).

Did this activity meet your educational needs?
Did this activity increase your competence?
Do you feel like there were any new data presented during this activity?

Did you learn anything new?

Did you gain confidence in your ability to act on the new information?

Did this activity include opportunities to learn as a part of a healthcare team?

Please answer the following question using a 5-point likert scale (5 = a great deal, 3 = a modest amount, 1 = nothing at all).

How much did you learn as a result of this session?

Please rate the following components related to this activity using a 5-point likert scale (5 = excellent, 3 = good, 1 = poor).

Content
Relevance to your practice 
Educational format 
Overall

Please rate the faculty on their knowledge, expertise, and teaching ability (5= excellent, 3 = good, 1 = poor).

Max Holder, MSN, RN, CRNI, NE-BC, VA, BC
Karen Laforet, RN, MCISc, CCHN(C), VA-BC, CVAA(c)

To what extent were the following learning objectives addressed by this activity (5 = entirely, 3 = moderately, 1 = not at all)?

Identify various sources of contamination that increase risks leading to catheter bloodstream infections
Explore clinical challenges associated with VAD maintenance that can impact outcomes  
Review the recommended guidelines, practices and evidence-based interventions for VAD maintenance to aid with the reduction of BSI risk
Identify strategies for prevention of VA related bloodstream infection in patients
The information presented in this activity was free of commercial bias.
How many patients do you encounter with bloodstream infections on a monthly basis?

Please now rate your ability to use currently available therapies to manage bloodstream infections.

Do you intend to make any changes to your practice as a result of information gained from this activity? Please be specific.

Which of the following barriers do you perceive in your efforts to implement practice changes and/or optimize patient care? Select all that apply.
255 characters max